Favipiravir

Coronavirus Updates: Maharashtra reports 14,492 new COVID-19 cases, 326 deaths; tally rises to 6,43,289

Coronavirus LIVE Updates: As many as 26 volunteers who reached the Air-India Express plane crash site in Kozhikode evacuated the injured passengers on 7 August, have tested positive for COVID-19

Coronavirus Updates: 11,514 new COVID-19 cases in Maharashtra today; tally rises to 4,79,779

Coronavirus LIVE Updates: The Maharashtra health department said that 11,514 COVID-19 cases and 316 deaths were reported in the state on Thursday. Total number of cases in the state is now at 4,79,779, including 1,46,305 active cases, 3,16,375 recovered and 16,792 deaths.

Zenara Pharma gets DCGI approval to sell Favipiravir tablet Favizen to treat mild to moderate COVID-19 infections

The company is in talks with various institutions to make the tablets available at discounted or no cost to underprivileged patients.

Lupin launches antiviral drug Favipiravir under the name Covihalt to treat mild to moderate COVID-19 infection

The Covihalt tablet will be available in 200 mg tablets in a strip of 10 and will cost Rs 49 per tablet in India.

Sunpharma launches Favipiravir tablet Fluguard to treat mild to moderate COVID-19 infections at Rs 35 per pill

Favipiravir is an antiviral drug that was originally made to treat influenza in Japan under the brand name Avigan.

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients

Favipiravir is an antiviral drug which was developed by a Japanese pharma company, Fujifilm Toyama Chemical, to treat influenza.

Coronavirus Outbreak Updates: Madhya Pradesh govt to promote 1st, 2nd year UG students based on previous scores; 1,128 cases in Mumbai today

Coronavirus Outbreak LIVE Updates: Tamil Nadu reported 2,710 new COVID-19 cases and 37 deaths, taking the total number of cases to 62,087 and death toll to 794. Number of active cases stands at 27,178.

Favipiravir is now the first oral COVID-19 treatment approved in India: All you need to know

Glenmark claims that favipiravir showed improvement of up to 88 percent in mild to moderate COVID-19 cases.

Hetero gets DCGI nod to launch anti-viral drug Remdesivir under brand name Covifor for COVID-19 treatment

The drug has been granted approval by DCGI for the treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children, hospitalised with severe symptoms of the disease, the company said.

Indian regulators give Glenmark approval to manufacture, sell favipiravir for ‘restricted emergency use’ in treating COVID-19 patients

Glenmark Pharmaceuticals Ltd has received Indian regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to-moderate COVID-19 infections in the country